Page 7 - Idorsia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Idorsia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Idorsia Today - Breaking & Trending Today

Idorsia Pharmaceuticals Ltd: Invitation to Idorsia's Q1 2023 Financial Results webcast and conference call

Idorsia will publish its first quarter financial results 2023 on Tuesday April 25, 2023, at 07:00 CEST. An investor conference call and webcast will be held to discuss the results on the same day. Date: ....

Andrewc Weiss , Corporate Communications , Tuesday April , Investor Relations ,

Invitation to Idorsia's Q1 2023 Financial Results webcast and conference call

Idorsia will publish its first quarter financial results 2023 on Tuesday April 25, 2023, at 07:00 CEST. An investor conference call and webcast will be held to discuss the results on the same day. . | April 18, 2023 ....

Andrewc Weiss , Corporate Communications , Tuesday April , Investor Relations , Idorsia Ltd Stock Exchange , Press Release , Ame Idia Ch0363463438 ,

Idorsia Pharmaceuticals Ltd: Idorsia issues invitation to the 2023 Annual General Meeting of Shareholders

Allschwil, Switzerland - April 6, 2023 Idorsia Ltd (SIX: IDIA) today issued the invitation to the upcoming Annual General Meeting (AGM) of Shareholders on behalf of the Board of Directors. The meeting ....

Switzerland General , Andrewc Weiss , Mathieu Simon , Sophie Kornowski , Messe Basel , Schweizerisches Handelsamtsblatt , Head Of Investor Relations Corporate Communications , Idorsia Ltd , Idorsia Pharmaceuticals Ltd , Approval Of Executive Committee , Articles Of Association , Swiss Exchange , Purpose Of The Company , Congress Center , Governance Compensation Committee , Company Annual , Annual General Meeting , Annual Report , Swiss Official Gazette , Compensation Report , Consolidated Financial Statements , Statutory Financial Statements , Compensation Committee , Executive Committee , Non Executive Directors , Vice President ,

Idorsia Pharmaceuticals Ltd: On World Sleep Day Idorsia highlights the publication of a global study on the economic and societal impact of chronic insomnia disorder

Chronic insomnia disorder (CID) is a persistent medical condition that prevents sufferers from getting restorative sleep1-3; research on wider societal and indirect economic costs associated with CID have ....

United States , Switzerland General , United Kingdom , Dennis Riedl , Andrewc Weiss , Jean Paul Clozel , Yerushalmie Troxel , Santa Monica , Marco Hafner , American Psychiatric Association , International Classification Of Sleep Disorders , World Sleep Society , Head Of Investor Relations Corporate Communications , University Of Freiburg , American Academy Of Sleep Medicine , University Of Zurich , Idorsia Ltd , Organization For Economic , Its Serious Public Health Implications , Institute For Employment Research , Senior Research Leader , Swiss Exchange , Pillars Of Health , More Important For Health , Idorsia Pharmaceuticals Ltd , International Study ,

Idorsia Pharmaceuticals UK Ltd.: New research reveals chronic insomnia disorder costs UK economy up to £34billion per year

First of its kind research indicates that if chronic insomnia disorder (CID) was treated effectively and comprehensively across the working age population, it could increase the GDP in the UK ....

City Of , United Kingdom , United States , Dennis Riedl , Yerushalmie Troxel , Santa Monica , Robert Moore , Marco Hafner , Kevin Bampton , Idorsia Ltd , American Psychiatric Association , International Classification Of Sleep Disorders , Organisation For Economic , British Occupational Hygiene Society , Institute For Employment Research , University Of Freiburg , Senior Research Leader , Swiss Exchange , American Academy Of Sleep Medicine , Impacts Task , Idorsia Pharmaceuticals Ltd , Idorsia United Kingdom Ltd , University Of Zurich , International Study , World Sleep Day , Idorsia United Kingdom ,